AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇲🇼

FUROSEMIDE in Malawi

12 products registered with PMRA 0 active, 12 expired

Brand / ProductReg. No.HolderStatusExpires
WW_FRUSE 20MG/2ML INJECTION
INJECTION
PMPB/PL381/11expired31 Mar 2025
LEFRUSID_40 40MG TABLET
TABLET
PMPB/PL108/50expired31 Mar 2025
FRUDIS 20MG/2ML INJECTION
INJECTION
PMPB/PL434/9expired31 Mar 2025
FUROSEMIDE 10MG/ML INJECTION
INJECTION
PMPB/PL388/5expired31 Mar 2024
DIASIK 40MG TABLET
TABLET
PMPB/PL359/44expired31 Mar 2024
PREMIDE 20MG/2ML INJECTION
INJECTION
PMPB/PL522/3expired31 Mar 2023
UROMID 40MG TABLET
TABLET
PMPB/PL161/8expired30 Jun 2021
UNOSEMIDE_10 10MG/ML INJECTION
INJECTION
PMPB/PL455/33expired30 Jun 2017
FUROSEMIDE 40MG TABLET
TABLET
PMPB/PL401/23expired30 Jun 2017
FUROSEMIDE 40MG TABLET
TABLET
PMPB/PL365/15expired30 Jun 2016
FUROSEMIDE 10MG/ML INJECTION
INJECTION
PMPB/PL152/2expired30 Jun 2012
FUROSEMIDE 40MG TABLET
TABLET
PMPB/PL275/23expired30 Jun 2012

FUROSEMIDEPMRA Registration Details

PMRA (Malawi) has 12 registered products containing FUROSEMIDE, of which 0 are currently active. Data is sourced directly from the official PMRA drug register and refreshed daily.

Track FUROSEMIDE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.

Furosemide — Malawi (PMRA) | AfricaRegulatory